NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0600
-0.1000 (-62.50%)
At close: Mar 24, 2026
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $7.84 million as of March 24, 2026. Its market cap has decreased by -68.39% in one year.
Market Cap
7.84M
Enterprise Value
46.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 7.84M, a decrease of -97.68%. That is a compound annual growth rate of -76.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 20.90M | 236.02% |
| Dec 31, 2025 | 6.22M | -73.65% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harvard Apparatus Regenerative Technology | 29.49M |
| Arch Biopartners | 27.04M |
| Provectus Biopharmaceuticals | 21.22M |
| Zenith Capital | 20.77M |
| EOM Pharmaceuticals Holdings | 20.23M |
| Oncotelic Therapeutics | 16.69M |
| Zeo ScientifiX | 15.32M |
| Inhibitor Therapeutics | 15.19M |